Portugal
Industry
BMI View: The ability and willingness of countries to pay back debts due to pharmaceutical companies across Europe is as important as the array of drug policy reforms that are enforcing...
2012-04-13Industry
BMI View: With hospital debt levels rising and payment times getting longer, we believe the Portuguese public hospital sector will remain a significant drag on pharmaceutical companies...
2012-03-27Industry
BMI Core View: The uptake of generic drugs following patent expiries will become swifter. This trend will reduce costs for governments, out-of-pocket payers and insurance companies,...
2010-05-25Industry
BMI Core View: The introduction of government price erosion mechanisms will accelerate across Europe. This view is supported by need for fiscal austerity and the actions of numerous...
2010-05-24Industry
High levels of Portuguese government debt have filtered through to the healthcare sector, with public hospitals owing the pharmaceutical industry around EUR625mn (US$856mn) in 2009....
2010-02-08Industry
Spanish drugmaker Faes Farma has signed an agreement with Laboratorios Cinfa for the joint marketing and distribution of generic drugs in Portugal. BMI commends the focus of the partnership...
2009-11-25Industry
The consumption of sedatives and antidepressants in Portugal is on the rise, according to the country's National Health Plan. Depression is significant problem for society, with its...
2009-08-03Industry
BMI's Drug Expenditure Forecast Model for Portugal has been indirectly validated by figures revealed by the Portuguese Association of the Pharmaceutical Industry (APIFARMA). On January...
2009-04-02
